Hiromi Nihommatsu

Learn More
AIM To evaluate the outcome predictors of percutaneous ablation therapy in patients with unresectable hepatocellular carcinoma (HCC), especially to identify whether the initial treatment response contributes to the survival of the patients. METHODS The study cohort included 153 patients with single (102) and two or three (51) HCC nodules 5 cm or less in(More)
  • 1